Skip to Content

Abacavir

In the US, Abacavir (abacavir systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat HIV Infection, Nonoccupational Exposure and Occupational Exposure.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AF06

CAS registry number (Chemical Abstracts Service)

0136470-78-5

Chemical Formula

C14-H18-N6-O

Molecular Weight

286

Therapeutic Categories

Antiviral agent

Nucleoside reverse transcriptase inhibitor (NRTI)

Treatment of HIV infection

Chemical Name

(1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-metanol (WHO)

Foreign Names

  • Abacavirum (Latin)
  • Abacavir (German)
  • Abacavir (French)
  • Abacavir (Spanish)

Generic Names

  • Abacavir (OS: BAN, DCF)
  • Abacavir Sulfate (OS: USAN, BANM, JAN)
  • 1592 U 89 sulfate (IS: GlaxoWellcome)
  • Abacavir Sulfate (PH: BP 2016, USP 38)
  • Abacavir sulfate (PH: Ph. Eur. 8, Ph. Int. 4)
  • Abacavir, sulfate de (PH: Ph. Eur. 8)
  • Abacaviri sulfas (PH: Ph. Eur. 8, Ph. Int. 4)
  • Abacavirsulfat (PH: Ph. Eur. 8)

Brand Names

  • Abacavir
    Eske, Peru
  • Abacavir Elea
    Elea, Argentina
  • Abacavir Humax
    Humax Pharmaceutical, Colombia
  • Abacavir Sulfate
    Aurobindo, Kenya
  • Abacavir/Lamivudine/Zidovudine Mylan (Abacavir and Lamivudine, + Zidovudine)
    Mylan, Netherlands
  • Abacavir/Lamivudine/Zidovudine Teva (Abacavir and Lamivudine, + Zidovudine)
    Teva, Netherlands; Teva Pharmaceuticals, Poland
  • Abamune
    Cipla, Georgia
  • Abavan
    OKASA, Peru
  • Abavir
    Cipla, Venezuela; Hetero, India
  • Abec
    Emcure, India
  • Adco-Abacavir
    Al Pharm, South Africa
  • Albavir Ped (Abacavir and Lamivudine (pediatric))
    Mylan, India
  • Aspen Abacavir
    Aspen Pharmacare, South Africa
  • Cipla-Abacavir
    Cipla Medpro, South Africa
  • Filabac
    Filaxis, Argentina
  • Kavimun Paed
    Mylan, South Africa
  • Kivexa (Abacavir and Lamivudine)
    Glaxo Group, Slovakia; GlaxoSmithKline, Finland; GlaxoSmithKline, Latvia; GlaxoSmithKline, Malaysia; ViiV Healthcare, Austria; ViiV Healthcare, Greece; Wellcome Limited, Bosnia & Herzegowina
  • Panka
    Microsules Arg, Argentina
  • Profelvir (Abacavir and Lamivudine)
    LKM, Argentina
  • Selmivir (Abacavir and Lamivudine)
    Richmond, Argentina
  • Sonke Abacavir
    Ranbaxy, South Africa
  • Triumeq (Abacavir and Dolutegravir, + Lamivudine)
    GlaxoSmithKline, Finland; ViiV Healthcare, Germany; ViiV Healthcare, Slovenia
  • Trivudin (Abacavir and Lamivudine, Zidovudine)
    Richmond, Argentina
  • Trizivir (Abacavir and Lamivudine, + Zidovudine)
    Glaxo Operations UK, Georgia; GlaxoSmithKline, China; GlaxoSmithKline, Ecuador; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Romania; GlaxoSmithKline, Taiwan; ViiV Healthcare, Italy; ViiV Healthcare, Poland; Viivhiv, Portugal; GlaxoSmithKline, Peru
  • Zepril
    Richmond, Argentina
  • Ziagen
    Glaxo Operations UK, Georgia; Glaxo Wellcome, Tunisia; GlaxoSmithKline, Peru; GlaxoSmithKline, Taiwan; GlaxoSmithKline, South Africa; GSK, Turkey; ViiV Healthcare, Tunisia
  • Abac
    Ranbaxy Laboratories LTD, Kenya
  • Dumiva (Abacavir and Lamivudine)
    Mylan, South Africa
  • Epzicom (Abacavir and Lamivudine)
    ViiV Healthcare, Japan; ViiV Healthcare, United States
  • Finecil
    LKM, Argentina
  • Idefirin
    Cryopharma, Mexico
  • Invertron
    Aurobindo, South Africa
  • Kivexa (Abacavir and Lamivudine)
    Glaxo Wellcome, Serbia; GlaxoSmithKline, Argentina; GlaxoSmithKline, Chile; GlaxoSmithKline, Colombia; GlaxoSmithKline, Denmark; GlaxoSmithKline, Ecuador; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Israel; GlaxoSmithKline, Mexico; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Romania; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Thailand; GlaxoSmithKline, Taiwan; GlaxoSmithKline, South Africa; ViiV, Australia; ViiV, Belgium; ViiV, Hungary; ViiV, Netherlands; ViiV Healthcare, Switzerland; ViiV Healthcare, Czech Republic; ViiV Healthcare, Germany; ViiV Healthcare, France; ViiV Healthcare, Ireland; ViiV Healthcare, Italy; ViiV Healthcare, Lithuania; ViiV Healthcare, Norway; ViiV Healthcare, Poland; Viiv Healthcare S.L., Spain; ViiV Healthcare UK, United Kingdom; ViiV Healthcare UK Limited, Iceland; ViiV Healthcare ULC, Canada; Viivhiv, Portugal
  • Lamcavir (Abacavir and Lamivudine)
    Humax Pharmaceutical, Colombia
  • Lamivudina + Zidovudina + Abacavir (Abacavir and Lamivudine, + Zidovudine)
    Humax Pharmaceutical, Colombia
  • Plusabcir
    Dosa, Argentina
  • Tivizid (Abacavir and Lamivudine + Zidovudine)
    Square, Bangladesh
  • Tricivir (Abacavir and Lamivudine, Zidovudine)
    GlaxoSmithKline, Argentina
  • Trilaxis (Abacavir and Lamivudine, Zidovudine)
    Filaxis, Argentina
  • Triumeq (Abacavir and Dolutegravir, + Lamivudine)
    GlaxoSmithKline, Chile; GlaxoSmithKline, Sweden; ViiV, Belgium; ViiV Healthcare, Switzerland; ViiV Healthcare, France; ViiV Healthcare, Ireland; ViiV Healthcare, United States; ViiV Healthcare UK, United Kingdom
  • Trizivir (Abacavir and Lamivudine, + Zidovudine)
    Glaxo Wellcome, Serbia; GlaxoSmithKline, Denmark; GlaxoSmithKline, Finland; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Israel; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Oman; GlaxoSmithKline, Sweden; ViiV, Australia; ViiV, Belgium; ViiV, Netherlands; ViiV Healthcare, Austria; ViiV Healthcare, Switzerland; ViiV Healthcare, Czech Republic; ViiV Healthcare, Germany; ViiV Healthcare, France; ViiV Healthcare, Greece; ViiV Healthcare, Ireland; ViiV Healthcare, Norway; ViiV Healthcare, United States; Viiv Healthcare S.L., Spain; ViiV Healthcare UK, United Kingdom; ViiV Healthcare UK Limited, Iceland; ViiV Healthcare ULC, Canada
  • Ziagen
    Glaxo Group, Lithuania; Glaxo Group, Slovakia; GlaxoSmithKline, Chile; GlaxoSmithKline, China; GlaxoSmithKline, Denmark; GlaxoSmithKline, Finland; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Israel; GlaxoSmithKline, Japan; GlaxoSmithKline, Latvia; GlaxoSmithKline, Malaysia; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; ViiV, Belgium; ViiV, Hungary; ViiV, Netherlands; ViiV Healthcare, Austria; ViiV Healthcare, Switzerland; ViiV Healthcare, Czech Republic; ViiV Healthcare, Germany; ViiV Healthcare, Greece; ViiV Healthcare, Ireland; ViiV Healthcare, Italy; ViiV Healthcare, Norway; ViiV Healthcare, Poland; ViiV Healthcare, United States; Viiv Healthcare S.L., Spain; ViiV Healthcare UK, United Kingdom; ViiV Healthcare UK Limited, Iceland; ViiV Healthcare ULC, Canada; Viivhiv, Portugal
  • Ziagenavir
    GlaxoSmithKline, Argentina; GlaxoSmithKline, Brazil; GlaxoSmithKline, Thailand
  • Zidomuv (Abacavir and Lamivudine, Zidovudine)
    LKM, Argentina

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide